(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

#1 CARDIOLOGIST RECOMMENDED ASPIRIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

#1 CARDIOLOGIST RECOMMENDED ASPIRIN

ST13

US500000078683251

Class

5

Filing

78683251

Registration

3138564

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

05/29/2026

Trademark type

Combined

Nice classes

5

Filing date

08/02/2005

Registration date

09/05/2006

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/09/2016

Last transaction

05/29/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

10/27/2004

First use in commerce

10/27/2004

Drawing code

3

Owner type

03

Owner location

Tarrytown, NY, US

Examiner

GAN, REBECCAH

Law office

L30

Current location

TMEG LAW OFFICE 103

Mark description

The mark consists of the top part of a stethoscope in the shape of a heart around a tablet with a pie shape piece missing and the outside of the tablet is the color orange; the words #1 CARDIOLOGIST RECOMMENDED ASPIRIN is across the middle of stethoscope.

Holders and representatives

Holders

Medtech Products Inc.
PRISM CH HOLDINGS INC.
GLAXOSMITHKLINE LLC
S. C. (pessoa física)

Representatives

Micheline Kelly Johnson SMITH, GAMBRELL & RUSSELL, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Analgesic preparations

Publications

History of USPTO decisions and trademark events.

38 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/22/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/22/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/22/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

04/01/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/24/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/24/2019

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/22/2017

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/09/2016

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

03/09/2016

XXXX

POST REGISTRATION ACTION CORRECTION

03/09/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/09/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

12/31/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED

09/21/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/21/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/21/2012

E815

TEAS SECTION 8 & 15 RECEIVED

08/30/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/30/2012

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/19/2012

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/19/2012

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/22/2012

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/08/2012

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/21/2011

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/27/2010

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/27/2010

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/23/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

09/05/2006

PUBO

PUBLISHED FOR OPPOSITION

06/13/2006

NPUB

NOTICE OF PUBLICATION

05/24/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

04/29/2006

ALIE

ASSIGNED TO LIE

04/21/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/20/2006

XAEC

EXAMINER'S AMENDMENT ENTERED

04/19/2006

GNEA

EXAMINERS AMENDMENT E-MAILED

04/18/2006

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/18/2006

GNRT

NON-FINAL ACTION E-MAILED

02/20/2006

CNRT

NON-FINAL ACTION WRITTEN

02/20/2006

DOCK

ASSIGNED TO EXAMINER

02/20/2006

NWAP

NEW APPLICATION ENTERED

08/08/2005

Continuous trademark protection

Get notified about every new filing that threatens #1 CARDIOLOGIST RECOMMENDED ASPIRIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.